Polymorphisms in IRF5 have been associated with multiple autoimmune diseases, particularly in systemic lupus erythematosus (SLE), primary Sjögren syndrome, and rheumatoid arthritis, which are characterized by significant sex differences in the disease prevalence [9, 21, 22]. Here, IRF5 is linked to rheumatoid arthritis.